Jaffetilchin Investment Partners LLC acquired a new stake in shares of National Health Investors, Inc. (NYSE:NHI) during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 3,883 shares of the real estate investment trust’s stock, valued at approximately $300,000. Jaffetilchin Investment Partners LLC owned 9,473.04% of National Health Investors at the end of the most recent reporting period.
A number of other hedge funds also recently modified their holdings of the business. Teachers Advisors LLC grew its stake in shares of National Health Investors by 2.3% during the first quarter. Teachers Advisors LLC now owns 63,197 shares of the real estate investment trust’s stock valued at $4,590,000 after buying an additional 1,420 shares during the last quarter. Dimensional Fund Advisors LP grew its stake in National Health Investors by 8.8% in the first quarter. Dimensional Fund Advisors LP now owns 542,845 shares of the real estate investment trust’s stock worth $39,426,000 after purchasing an additional 43,890 shares in the last quarter. Renaissance Technologies LLC bought a new position in National Health Investors in the first quarter worth approximately $4,796,000. BlackRock Inc. grew its stake in National Health Investors by 6,473.4% in the first quarter. BlackRock Inc. now owns 3,328,567 shares of the real estate investment trust’s stock worth $241,753,000 after purchasing an additional 3,277,930 shares in the last quarter. Finally, Schwab Charles Investment Management Inc. grew its stake in National Health Investors by 9.7% in the first quarter. Schwab Charles Investment Management Inc. now owns 161,309 shares of the real estate investment trust’s stock worth $11,716,000 after purchasing an additional 14,297 shares in the last quarter. Institutional investors and hedge funds own 70.13% of the company’s stock.
ILLEGAL ACTIVITY NOTICE: “Jaffetilchin Investment Partners LLC Acquires New Stake in National Health Investors, Inc. (NHI)” was first posted by Sports Perspectives and is the property of of Sports Perspectives. If you are viewing this report on another publication, it was stolen and reposted in violation of international trademark & copyright law. The correct version of this report can be read at https://sportsperspectives.com/2017/11/11/jaffetilchin-investment-partners-llc-acquires-new-stake-in-national-health-investors-inc-nhi.html.
Several brokerages recently issued reports on NHI. BidaskClub cut National Health Investors from a “hold” rating to a “sell” rating in a research note on Wednesday, August 9th. ValuEngine upgraded National Health Investors from a “hold” rating to a “buy” rating in a report on Friday. Zacks Investment Research upgraded National Health Investors from a “hold” rating to a “buy” rating and set a $86.00 target price for the company in a report on Friday. Mizuho restated a “hold” rating and set a $82.00 target price on shares of National Health Investors in a report on Wednesday, October 4th. Finally, BMO Capital Markets restated a “hold” rating and set a $80.00 target price on shares of National Health Investors in a report on Wednesday, October 18th. One research analyst has rated the stock with a sell rating, seven have issued a hold rating and three have given a buy rating to the company. National Health Investors presently has an average rating of “Hold” and an average target price of $80.14.
National Health Investors, Inc. (NYSE:NHI) opened at $76.66 on Friday. National Health Investors, Inc. has a 52 week low of $67.33 and a 52 week high of $81.21. The stock has a market capitalization of $3,174.30, a price-to-earnings ratio of 14.67, a P/E/G ratio of 3.78 and a beta of 0.58. The company has a debt-to-equity ratio of 0.84, a current ratio of 12.72 and a quick ratio of 12.45.
National Health Investors (NYSE:NHI) last announced its quarterly earnings results on Wednesday, August 9th. The real estate investment trust reported $0.93 earnings per share for the quarter, missing analysts’ consensus estimates of $1.29 by ($0.36). National Health Investors had a net margin of 59.70% and a return on equity of 12.74%. The company had revenue of $69.84 million during the quarter, compared to analysts’ expectations of $67.68 million. During the same period last year, the firm earned $1.22 earnings per share. National Health Investors’s revenue was up 14.1% on a year-over-year basis. analysts forecast that National Health Investors, Inc. will post 5.26 earnings per share for the current fiscal year.
The business also recently declared a quarterly dividend, which will be paid on Wednesday, January 31st. Investors of record on Friday, December 29th will be given a $0.95 dividend. The ex-dividend date of this dividend is Thursday, December 28th. This represents a $3.80 dividend on an annualized basis and a yield of 4.96%. National Health Investors’s dividend payout ratio (DPR) is presently 95.00%.
In related news, insider Kevin Carlton Pascoe sold 2,000 shares of the business’s stock in a transaction on Thursday, August 24th. The shares were sold at an average price of $79.80, for a total value of $159,600.00. Following the completion of the sale, the insider now directly owns 21,228 shares of the company’s stock, valued at $1,693,994.40. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. 5.19% of the stock is owned by insiders.
National Health Investors Company Profile
National Health Investors, Inc is a self-managed real estate investment trust (REIT) specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. The Company is engaged in the business of owning and financing healthcare properties.
Receive News & Ratings for National Health Investors Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors Inc. and related companies with MarketBeat.com's FREE daily email newsletter.